Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 751 Jul 26 – Oct 23, 2026
- Disclosed funding
- $68.6B 606 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| NM N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
| A ArchiveCompany profile A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. | Undisclosed | Growth investmentGrowth | Media & gaming | United States | Investors | |
| N NewlightCompany profile Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. | $9M | Seed | Climate tech | United States | Investors | |
| TT Typewriter TherapeuticsCompany profile Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. | $56M | Series A | Biotech | United States | Investors | |
| LR Locus RoboticsCompany profile Locus Robotics supplies autonomous mobile robots and LocusONE software to warehouse and distribution operators. Locus Robotics supplies autonomous mobile robots and LocusONE software to warehouse and distribution operators. | $41.6M | Series GSeries C+ | Robotics | United States | Investors | |
| E ElucidCompany profile Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. | $55M | Series DSeries C+ | Healthtech | United States | Investors | |
| C CariCompany profile A bank-governed network for moving tokenized commercial-bank deposits in programmable, always-on transactions between participating financial institutions. A bank-governed network for moving tokenized commercial-bank deposits in programmable, always-on transactions between participating financial institutions. | $32.5M | FundingUndisclosed | Fintech | United States | Investors | |
| T TabaPayCompany profile TabaPay provides a unified API for businesses to accept payments and move funds instantly across cards, bank accounts and payment networks. Fintechs, lenders and other platforms use it to collect money and send payouts through the rails their customers can access. TabaPay provides a unified API for businesses to accept payments and move funds instantly across cards, bank accounts and payment networks. Fintechs, lenders and other platforms use it to collect money and send payouts through the rails their customers can access. | $155M | Series B strategic growth financingSeries B | Fintech | United States | Investors | |
| OO Outcomes OneCompany profile Outcomes One connects pharmacies, health plans, and drug manufacturers through clinical-care programs and pharmacy workflow software. Outcomes One connects pharmacies, health plans, and drug manufacturers through clinical-care programs and pharmacy workflow software. | Undisclosed | Growth investmentGrowth | Healthtech | United States | Investors | |
| S SciFinCompany profile SciFin gives enterprise revenue teams a continuously updated view of accounts, deals, forecasts, territories and customer conversations. Its AI companion, Pixie, uses that connected context to answer business questions, identify risks, prepare reports and recommend follow-up actions. SciFin gives enterprise revenue teams a continuously updated view of accounts, deals, forecasts, territories and customer conversations. Its AI companion, Pixie, uses that connected context to answer business questions, identify risks, prepare reports and recommend follow-up actions. | $44M | Seed | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 26, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
55rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
42rounds16led - 3Khosla Ventures
Arda Industries, Tolan
25rounds6led - 4Sequoia Capital
Warhound, Whop, Blacksmith
23rounds7led - 5Alumni Ventures
Maxinsights, Daytona, Chariot Claims
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.